ArticlePlastic and reconstructive surgery. Global open2025
Navigating Private Equity Buyouts: A Guide for Plastic Surgeons at All Career Stages.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recently, private equity (PE) investments in plastic surgery have increased as senior surgeons retire and transfer their legacy practices to corporate ownership in exchange for substantial payouts. During this transition, clinicians and practitioners at acquired practices often feel skeptical about the organization's goals and future. If left unaligned, the relationship between these groups deteriorates, and consequently, so does the quality of clinical care. Although the medical literature on this topic highlights the risks of PE, it often fails to address strategies for fostering a healthy working relationship among these groups. Methods: A comprehensive review of the medical business management literature was conducted to identify potential solutions applicable to clinical settings. Results: PE acquisitions typically give rise to 5 core concerns: future uncertainty, salary cuts or job losses, increased workloads, loss of clinical autonomy, and unclear organizational and career prospects. This article identifies recommendations tailored to both clinicians and PE leaders to improve integration, alignment, and productive partnerships. These recommendations address the unique concerns and aspirations of physicians at various stages of their careers within the PE landscape, with the overarching goal of enhancing practice valuation and achieving career success without compromising patient care. Conclusions: Drawing insights from business management, this article proposes actionable steps to improve the integration of PE firms into plastic surgery practices. A collaborative partnership can benefit all stakeholders-physicians, practices, PE investors, and patients-while safeguarding the quality of patient care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.